Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk

被引：11
|
作者：
Arnott, Clare [1 ,2 ,3 ]
Fletcher, Robert A. [1 ]
Neal, Bruce [1 ,4 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Level 5,1 King St, Sydney, NSW 2042, Australia
[2] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[4] Imperial Coll London, Dept Epidemiol & Biostat, London, England
来源：
HEART FAILURE CLINICS | 2022年 / 18卷 / 04期
关键词：
SGLT2; inhibitors; Meta-analysis; Amputation; Fracture; TYPE-2; CANAGLIFLOZIN;
D O I：
10.1016/j.hfc.2022.03.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：645 / 654
页数：10
相关论文
共 50 条
  • [21] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Yu, Teng-Shun
    Hung, Yu-Tung
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    JAMA NETWORK OPEN, 2023, 6 (12) : E2348431
  • [22] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
    Jasleen, Bains
    Vishal, Gupta K.
    Sameera, Malepati
    Fahad, Molla
    Brendan, O'Brien
    Deion, Santander
    Pemminati, Sudhakar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [23] Sodium-Glucose Cotransporter-2 Inhibitors and Lower-Extremity Amputation
    Aizawa, Yoshifusa
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 201 : 388 - 389
  • [24] Sodium Glucose Cotransporter 2 Inhibitors
    White, John R., Jr.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (01) : 131 - +
  • [25] Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [26] Characterization of Risk Factors for Genitourinary Infections with Sodium-Glucose Cotransporter-2 Inhibitors
    Benjamin, Trisha
    Schumacher, Christine
    PHARMACOTHERAPY, 2020, 40 (10): : 1002 - 1011
  • [27] Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Abnormal Serum Potassium Level
    Hwang, Y. Joseph
    Lyu, Beini
    Chang, Alex R.
    Inker, Lesley A.
    Grams, Morgan E.
    Shin, Jung-Im
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (07): : 1094 - 1096
  • [28] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice-Reply
    Paik, Julie M.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (07)
  • [29] Treatment with sodium-glucose cotransporter 2 inhibitors and risk of lower-limb amputations
    Tkac, Ivan
    Kozarova, Miriam
    Stancakova Yaluri, Alena
    Javorsky, Martin
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4803 - 4805
  • [30] Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Kleinjan, Jan P.
    Blom, Justin
    van Beek, Andre P.
    Bouma, Hjalmar R.
    van Dijk, Peter R.
    METABOLITES, 2024, 14 (03)
12345